Background A 78-year-old man with a 22-year history of schizoaffective disorder and a 5-year history of dementia presented to the emergency department with a 5-day history of fatigue, progressive ...

What is Neuroleptic Malignant Syndrome and What Causes It? Neuroleptic malignant syndrome (NMS) is a life-threatening, neurological disorder. Most often, it’s an adverse reaction to neuroleptic or ...

A timely diagnosis and discontinuation of antipsychotic therapy stand as first-line treatment for neuroleptic malignant syndrome (NMS), followed by supportive care and pharmacotherapy, a review ...

This page lists all known medications that could potentially lead to 'Neuroleptic malignant syndrome' as a side effect. It's important to note that mild side effects are quite common with medications.

This patient developed NMS after BMT but improved after discontinuation haloperidol, a neuroleptic drug known to be associated with NMS. NMS complicating BMT has only been reported by Garrido and ...

Geethan J. Chandran and associates, in their report of a case of neuroleptic malignant syndrome (NMS),1 describe an 81-year-old man who was given 2 dopamine D 2 blocking agents, with a total daily ...

Background "Neuroleptic malignant syndrome" (NMS) is a potentially fatal idiosyncratic reaction to any medication which affects the central dopaminergic system. Between 0.5% and 1% of patients exposed ...

In their presentation of a case of rhabdomyolysis possibly associated with mRNA SARS-CoV-2 vaccination, Salter and colleagues1 are to be commended for elucidating the relevant differential diagnosis, ...

"Neuroleptic malignant syndrome" (NMS) derives from the French "syndrome malin des neuroleptiques" and was first described in 1960 by Delay [1] and colleagues in association with haloperidol. It is a ...